We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer, Mylan Await Decision In Norvasc Patent Case

Law360 (December 7, 2006, 12:00 AM EST) -- After a seven-day bench trial, attorneys for Pfizer Inc. and generic drug maker Mylan Pharmaceuticals Inc. made closing arguments Wednesday, putting the final touch on a longstanding patent infringement suit over...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.